Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Aug;37(2):679–686. doi: 10.1128/iai.37.2.679-686.1982

Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.

P N Fultz, J A Shadduck, C Y Kang, J W Streilein
PMCID: PMC347585  PMID: 6180986

Abstract

Homologous defective interfering (DI) particles protected adult Syrian hamsters against lethal systemic infection with vesicular stomatitis virus (VSV) serotype Indiana. The DI particles had to be biologically active, but did not have to be administered at the same inoculation site as the infectious virus. Serum and tissue levels of VSV postinoculation were significantly lower in DI-protected animals than in unprotected controls, suggesting that true autointerference was occurring. However, some aspects of protection also must be mediated through nonspecific mechanisms, since susceptible hamsters could be protected against VSV Indiana by coinjection with heterologous DI particles prepared from VSV serotype New Jersey or by simultaneous administration of polyinosinic acid-polycytidylic acid. By measuring serum levels of putative hamster interferon (type 1), we found that animals coinjected with VSV and DI particles or polyinosinic acid-polycytidylic acid produced significant levels of interferon. Since similarly high serum levels of interferon were measured in recipients of VSV alone (animals that eventually died from infection), there appeared to be no correlation between protection against lethal disease and induced levels of serum interferon. Instead, serum interferon levels correlated positively with amounts of VSV PFU found in serum and tissues of infected animals, the lowest levels being found in serum of animals protected with homologous DI particles. The data are consistent with the hypothesis that autointerference by DI particles as well as various host defense mechanisms (possibly including induction of interferon) participates in protecting hamsters against lethal VSV infection.

Full text

PDF
679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bay P. H., Reichmann M. E. UV inactivation of the biological activity of defective interfering particles generated by vesicular stomatitis virus. J Virol. 1979 Dec;32(3):876–884. doi: 10.1128/jvi.32.3.876-884.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bradish C. J., Titmuss D. The effects of interferon and double-stranded RNA upon the virus-host interaction: studies with togavirus strains in mice. J Gen Virol. 1981 Mar;53(Pt 1):21–30. doi: 10.1099/0022-1317-53-1-21. [DOI] [PubMed] [Google Scholar]
  3. Cartwright B., Brown F. Serological relationships between different strains of vesicular stomatis virus. J Gen Virol. 1972 Sep;16(3):391–398. doi: 10.1099/0022-1317-16-3-391. [DOI] [PubMed] [Google Scholar]
  4. Clark H. F., Parks N. F., Wunner W. H. Defective interfering particles of fixed rabies viruses: lack of correlation with attenuation or auto-interference in mice. J Gen Virol. 1981 Feb;52(Pt 2):245–258. doi: 10.1099/0022-1317-52-2-245. [DOI] [PubMed] [Google Scholar]
  5. Clewley J. P., Bishop D. H., Kang C. Y., Coffin J., Schnitzlein W. M., Reichmann M. E., Shope R. E. Oligonucleotide fingerprints of RNA species obtained from rhabdoviruses belonging to the vesicular stomatitis virus subgroup. J Virol. 1977 Jul;23(1):152–166. doi: 10.1128/jvi.23.1.152-166.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crick J., Brown F. In vivo interference in vesicular stomatitis virus infection. Infect Immun. 1977 Feb;15(2):354–359. doi: 10.1128/iai.15.2.354-359.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dimmock N. J., Kennedy S. I. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus. J Gen Virol. 1978 May;39(2):231–242. doi: 10.1099/0022-1317-39-2-231. [DOI] [PubMed] [Google Scholar]
  8. Doyle M., Holland J. J. Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. Proc Natl Acad Sci U S A. 1973 Jul;70(7):2105–2108. doi: 10.1073/pnas.70.7.2105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fultz P. N., Shadduck J. A., Kang C. Y., Streilein J. W. Genetic analysis of resistance to lethal infections of vesicular stomatitis virus in Syrian hamsters. Infect Immun. 1981 Jun;32(3):1007–1013. doi: 10.1128/iai.32.3.1007-1013.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fultz P. N., Shadduck J. A., Kang C. Y., Streilein J. W. Involvement of cells of hematopoietic origin in genetically determined resistance of Syrian hamsters to vesicular stomatitis virus. Infect Immun. 1981 Nov;34(2):540–549. doi: 10.1128/iai.34.2.540-549.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gresser I., Tovey M. G., Bourali-Maury C. Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice. J Gen Virol. 1975 Jun;27(3):395–398. doi: 10.1099/0022-1317-27-3-395. [DOI] [PubMed] [Google Scholar]
  12. Haller O., Arnheiter H., Horisberger M. A., Gresser I., Lindenmann J. Interaction between interferon and host genes in antiviral defense. Ann N Y Acad Sci. 1980;350:558–565. doi: 10.1111/j.1749-6632.1980.tb20657.x. [DOI] [PubMed] [Google Scholar]
  13. Havell E. A., Spitalny G. L. The induction and characterization of interferon from pure cultures of murine macrophages. Ann N Y Acad Sci. 1980;350:413–421. doi: 10.1111/j.1749-6632.1980.tb20643.x. [DOI] [PubMed] [Google Scholar]
  14. Huang A. S., Baltimore D. Defective viral particles and viral disease processes. Nature. 1970 Apr 25;226(5243):325–327. doi: 10.1038/226325a0. [DOI] [PubMed] [Google Scholar]
  15. Jahrling P. B., Navarro E., Scherer W. F. Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters. Arch Virol. 1976;51(1-2):23–35. doi: 10.1007/BF01317831. [DOI] [PubMed] [Google Scholar]
  16. Jones C. L., Holland J. J. Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo. J Gen Virol. 1980 Jul;49(1):215–220. doi: 10.1099/0022-1317-49-1-215. [DOI] [PubMed] [Google Scholar]
  17. Kang C. Y., Glimp T., Clewley J. P., Bishop D. H. Studies on the generation of vesicular stomatitis virus (indiana serotype) defective interfering particles. Virology. 1978 Jan;84(1):142–152. doi: 10.1016/0042-6822(78)90226-x. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Lieberman M., Pascale A., Schafer T. W., Came P. E. Effect of antiviral agents in equine abortion virus-infected hamsters. Antimicrob Agents Chemother. 1972 Feb;1(2):143–147. doi: 10.1128/aac.1.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Maheshwari R. K., Friedman R. M. Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity. Virology. 1980 Mar;101(2):399–407. doi: 10.1016/0042-6822(80)90453-5. [DOI] [PubMed] [Google Scholar]
  21. McNeill T. A., Fleming W. A., McCance D. J. Interferon and haemopoietic colony inhibitor responses to poly I-poly C in rabbits and hamsters. Immunology. 1972 May;22(5):711–721. [PMC free article] [PubMed] [Google Scholar]
  22. Popescu M., Lehmann-Grube F. Defective interfering particles in mice infected with lymphocytic choriomeningitis virus. Virology. 1977 Mar;77(1):78–83. doi: 10.1016/0042-6822(77)90407-x. [DOI] [PubMed] [Google Scholar]
  23. Prevec L., Kang C. Y. Homotypic and heterotypic interference by defective particles of vesicular stomatitis virus. Nature. 1970 Oct 3;228(5266):25–27. doi: 10.1038/228025a0. [DOI] [PubMed] [Google Scholar]
  24. Rabinowitz S. G., Huprikar J. The influence of defective-interfering particles of the PR-8 strain of influenza A virus on the pathogenesis of pulmonary infection in mice. J Infect Dis. 1979 Sep;140(3):305–315. doi: 10.1093/infdis/140.3.305. [DOI] [PubMed] [Google Scholar]
  25. Renis H. E. Effect of poly I: C on experimental respiratory infection in hamsters. Appl Microbiol. 1970 Nov;20(5):821–824. doi: 10.1128/am.20.5.821-824.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Spandidos D. A., Graham A. F. Generation of defective virus after infection of newborn rats with reovirus. J Virol. 1976 Oct;20(1):234–247. doi: 10.1128/jvi.20.1.234-247.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Welsh R. M., Lampert P. W., Oldstone M. B. Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus. J Infect Dis. 1977 Sep;136(3):391–399. doi: 10.1093/infdis/136.3.391. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES